Antipsychotic Measures Available for Public Comment
New
measures to assess the safe and judicious use of antipsychotics in
children and adolescents are being developed by the National
Collaborative for Innovation in Quality Measurement (NCINQ) Center of
Excellence under the Agency for Healthcare Research and Quality-Centers
for Medicare & Medicaid Services (AHRQ-CMS) Children’s Health
Insurance Program Reauthorization Act (CHIPRA) Pediatric Quality
Measures Program. The proposed measures are being posted for the
Health Care Effectiveness Data and Information Set (HEDIS) Public
Comment during the period February 19-March 19, 2014. All
feedback submitted within the Public Comment period is reviewed by
National Committee for Quality Assurance (NCQA). For more information or
to submit a comment:
No hay comentarios:
Publicar un comentario